Comedian Amy Schumer shared that she is on a new weight loss drug after experiencing severe side effects from Ozempic. Amy Schumer/Instagram “They put me on estrogen and progesterone because I ...

Amy Schumer revealed she’s on a new weight loss medication after her last attempt on the drugs left her so nauseous she couldn’t lift her head off the pillow. “Mounjaro’s been great ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

Long-term hair loss seems to be more unlikely, the doctor said, as the “inciting event” (weight loss and stress) often normalizes as individuals reach their target weight. Potential limitations ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

As more doctors and patients turn to the latest weight-loss drugs, researchers are trying to figure out which drug is right for which patient—and at what point in their weight-loss journey.

Originally, there were 41,222 adults meeting the study criteria. The racial makeup was 77.1% white, 11.8% Black, 1.9% Asian and the remainder segment unknown.

Amy Schumer's experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication years ago. Schumer, 43, praised the effects of Mounjaro (also known as ...

Amy Schumer revealed she’s on a new weight loss medication after her last attempt on the drugs left her so nauseous she couldn’t lift her head off the pillow. “Mounjaro’s been great ...